Dr. David Egilman, a physician and expert witness who, over a 35-year span, gave testimony in some 600 trials involving corporate malfeasance, resulting in billions of dollars in awards for victims and their survivors, died on April 2 at his home in Foxborough, Mass. He was 71. The cause was cardiac arrest, his son Alex…
Historically speaking, it’s not a bad time to be the liver of a teenager. Or the lungs. Regular use of alcohol, tobacco and drugs among high school students has been on a long downward trend. In 2023, 46 percent of seniors said that they’d had a drink in the year before being interviewed; that is…
The maker of the newest treatment approved for amyotrophic lateral sclerosis said Thursday that it would withdraw the drug from the market because a large clinical trial did not produce evidence that the treatment worked. The company, Amylyx Pharmaceuticals, said in a statement that it had started the process of withdrawing the drug in the…
The Food and Drug Administration has greenlit a new medicine to protect some of the people most at riskfrom Covid. The agency granted emergency use authorization for Pemgarda, a monoclonal antibody infusion, in immunocompromised people ages 12 and older. The drug is intended to protect against Covid for people who are not likely to mount…
First the cartel cut its teeth with drug trafficking. Then avocados, real estate and construction companies. Now, a Mexican criminal group known for its brutality is moving in on seniors and their timeshares. The operation is relatively simple. Cartel employees posing as sales representatives call up timeshare owners, offering to buy their investments back for…
The death certificate for Ryan Bagwell, a 19-year-old from Mission, Texas, states that he died from a fentanyl overdose. His mother, Sandra Bagwell, says that is wrong. On an April night in 2022, he swallowed one pill from a bottle of Percocet, a prescription painkiller that he and a friend bought earlier that day at…
One of the few treatments the Food and Drug Administration has approved for amyotrophic lateral sclerosis has failed a large clinical trial, and its manufacturer said Friday that it was considering whether to withdraw it from the market. The medication, called Relyvrio, was approved less than two years ago, despite questions about its effectiveness in…
The Food and Drug Administration has decided to delay action on a closely watched Alzheimer’s drug, donanemab, which the agency was widely expected to approve this month. The F.D.A. will instead require donanemab to undergo the scrutiny of a panel of independent experts, the drug’s maker, Eli Lilly and Company, said Friday. “The F.D.A. has…
The drug company Atai Life Sciences is spending millions to research the compound, and congressional lawmakers from both parties have been pushing the government to promote ibogaine research for substance abuse, post-traumatic stress disorder and other mental health problems. For Dr. Deborah Mash, a professor of neurology at the University of Miami who began studying…
The drug company Atai Life Sciences is spending millions to research the compound, and congressional lawmakers from both parties have been pushing the government to promote ibogaine research for substance abuse, post-traumatic stress disorder and other mental health problems. For Dr. Deborah Mash, a professor of neurology at the University of Miami who began studying…
